Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression

Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression

Effective interventions for neuropsychiatric disorders may work by rebalancing the brain’s functional hierarchical organization. Here we directly investigated the effects of two different serotonergic pharmacological interventions on functional brain hierarchy in major depressive disorder in a two-a...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Deco, G, Sanz Perl, Y, Johnson, S, Bourke, N, Carhart-Harris, RL, Kringelbach, ML
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Nature Research 2024

Gelijkaardige items

Brain dynamics predictive of response to psilocybin for treatment-resistant depression
door: Vohryzek, J, et al.
Gepubliceerd in: (2024)

Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin
door: Lord, L-D, et al.
Gepubliceerd in: (2019)

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”
door: Julia Bornemann, et al.
Gepubliceerd in: (2024-06-01)

Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT)
door: Piccinini, JI, et al.
Gepubliceerd in: (2025)

Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder
door: Escrichs, A, et al.
Gepubliceerd in: (2024)

Turbulent dynamics and whole-brain modeling: toward new clinical applications for traumatic brain injury
door: Noelia Martínez-Molina, et al.
Gepubliceerd in: (2024-03-01)

Effects of escitalopram therapy on functional brain controllability in major depressive disorder
door: Fang, F, et al.
Gepubliceerd in: (2022)

Psychotherapy with Psilocybin for Depression: Systematic Review
door: Jonathan Joseph Dawood Hristova, et al.
Gepubliceerd in: (2023-03-01)

Escitalopram versus other antidepressive agents for depression.
door: Cipriani, A, et al.
Gepubliceerd in: (2009)

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD
door: Atasoy, S, et al.
Gepubliceerd in: (2017)

Scaling of whole-brain dynamics reproduced by high-order moments of turbulence indicators
door: Yonatan Sanz Perl, et al.
Gepubliceerd in: (2023-09-01)

Study protocol for “psilocybin as a treatment for anorexia nervosa: a pilot study”
door: Spriggs, MJ, et al.
Gepubliceerd in: (2021)

Psilocybin as a new way for depression treatment
door: Mateusz Maciej Pawlicki, et al.
Gepubliceerd in: (2024-05-01)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
door: Omar Gammoh, et al.
Gepubliceerd in: (2023-09-01)

P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study
door: Douglass, H, et al.
Gepubliceerd in: (2021)

Re-awakening the brain: Forcing transitions in disorders of consciousness by external in silico perturbation
door: Dagnino, PC, et al.
Gepubliceerd in: (2024)

THE EMERGENCE OF THE ARROW OF TIME IN WHOLE-BRAIN DYNAMICS
door: Sebastian Geli, et al.
Gepubliceerd in: (2023-10-01)

Risks of using psilocybin in treatment of treatment-resistant depression
door: Michał Orzechowski, et al.
Gepubliceerd in: (2025-03-01)

The development of psilocybin therapy for treatment-resistant depression: an update
door: Anya Borissova, et al.
Gepubliceerd in: (2024-02-01)

Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
door: Antonio Munafò, et al.
Gepubliceerd in: (2022-12-01)

Effects of psilocybin-assisted therapy on treatment-resistant depression
door: A. Fraga, et al.
Gepubliceerd in: (2021-04-01)

The therapeutic potential of psilocybin in depression resistant to psychotropic drugs
door: J. Ramírez González, et al.
Gepubliceerd in: (2023-03-01)

Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression
door: M. C. Q. Lin, et al.
Gepubliceerd in: (2023-03-01)

Association of Psilocybin Use in Adolescents with Major Depressive Episode
door: K. Shah, et al.
Gepubliceerd in: (2022-06-01)

Escitalopram in patients with psoriasis
door: M. Artemieva, et al.
Gepubliceerd in: (2021-04-01)

The evolution of whole-brain turbulent dynamics during recovery from traumatic brain injury
door: Noelia Martínez-Molina, et al.
Gepubliceerd in: (2024-02-01)

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
door: Sara de la Salle, et al.
Gepubliceerd in: (2024-07-01)

Use of escitalopram to prevent depression and cognitive impairments in the acute phase of stroke
door: Dina Rustemovna Khasanova, et al.
Gepubliceerd in: (2013-11-01)

Review of the brain areas activated in fMRI after escitalopram antidepressant treatment inpatients with major depressive disorder
door: Mao Yi, et al.
Gepubliceerd in: (2021-08-01)

Oxygen and the spark of human brain evolution: complex interactions of metabolism and cortical expansion across development and evolution
door: Luppi, AI, et al.
Gepubliceerd in: (2022)

Navigating Pubertal Goldilocks: The Optimal Pace for Hierarchical Brain Organization
door: Hanna Szakács, et al.
Gepubliceerd in: (2024-06-01)

Whole-brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD
door: Deco, G, et al.
Gepubliceerd in: (2018)

Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder
door: Sandra Szafoni, et al.
Gepubliceerd in: (2024-06-01)

Escitalopram-Induced Hyperprolactinemic Galactorrhea
door: Deepthi Yedla, et al.
Gepubliceerd in: (2022-10-01)

The Relationship Between Theta Power, Theta Asymmetry and the Effect of Escitalopram in the Treatment of Depression
door: Gao M, et al.
Gepubliceerd in: (2023-10-01)

Psilocybin: Psychotherapy or drug?
door: Goodwin, G
Gepubliceerd in: (2016)

The Therapeutic Potential of Psilocybin
door: Henry Lowe, et al.
Gepubliceerd in: (2021-05-01)

Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis
door: Metaxa, A, et al.
Gepubliceerd in: (2024)

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
door: Richard J. Zeifman, et al.
Gepubliceerd in: (2023-08-01)

The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin
door: Tobias P. Whelan, et al.
Gepubliceerd in: (2024-04-01)